iniuva GmbH / UKE Hamburg
EN: Prof. Dr. med. Søren Gersting is CEO of iniuva GmbH and Professor of Paediatric Research at the UKE in Hamburg. His work combines rare genetic disorders, protein misfolding and pharmacological chaperones with AI-assisted drug discovery to make therapies for rare diseases available more quickly and precisely. DE: Prof. Dr. med. Søren Gersting ist CEO der iniuva GmbH und Professor für Pädiatrische Forschung am UKE Hamburg. Seine Arbeit verbindet seltene genetische Erkrankungen, Proteinfehlfaltung und pharmacological chaperones mit KI-gestützter Wirkstoffentwicklung, um Therapien für seltene Erkrankungen schneller und präziser zugänglich zu machen.
Emma has to go back to the hospital again and again – not because her doctors don’t care, but because there is simply no approved therapy for her rare disease. Her story is not unique: millions of children and patients worldwide are in the same situation. In this session, Profes…
